Evidence map›Paper›PMID 28651694›Full record

ArticleProstaglandins, leukotrienes, and essential fatty acids2017

Maternal plasma phosphatidylcholine polyunsaturated fatty acids during pregnancy and offspring growth and adiposity.

Jonathan Y Bernard, Mya-Thway Tint, Izzuddin M Aris, Ling-Wei Chen, Phaik Ling Quah, Kok Hian Tan, George Seow-Heong Yeo, Marielle V Fortier, Fabian Yap, Lynette Shek and 8 more

Abstract read
In one paragraph

Article in Prostaglandins, leukotrienes, and essential fatty acids, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. [Research advances in the effect of long-chain polyunsaturated fatty acids on neonates].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2021
    Review
  11. Review
  12. Article
  13. New Approaches to Fetal Growth Restriction: The Time for Metabolomics Has Come.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2019
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 5 countries.

Jonathan Y BernardSingapore Institute for Clinical Sciences, Agency for Science Technology and Research (A⁎STAR), Singapore. Electronic address: jonathan_bernard@sics.a-star.edu.sg.
Mya-Thway TintDepartment of Obstetrics & Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore.
Izzuddin M ArisSingapore Institute for Clinical Sciences, Agency for Science Technology and Research (A⁎STAR), Singapore.
Ling-Wei ChenDepartment of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Phaik Ling QuahSingapore Institute for Clinical Sciences, Agency for Science Technology and Research (A⁎STAR), Singapore.
Kok Hian TanDepartment of Maternal Fetal Medicine, KK Women's and Children's Hospital, Singapore; Duke-NUS Medical School, Singapore.
George Seow-Heong YeoDepartment of Obstetrics & Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore; Department of Maternal Fetal Medicine, KK Women's and Children's Hospital, Singapore; Duke-NUS Medical School, Singapore.
Marielle V FortierDepartment of Diagnostic and Interventional Imaging, KK Women's and Children's Hospital, Singapore.
Fabian YapDepartment of Paediatrics, KK Women's and Children's Hospital, Singapore.
Lynette ShekSingapore Institute for Clinical Sciences, Agency for Science Technology and Research (A⁎STAR), Singapore; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Paediatric Allergy, Immunology & Rheumatology, Khoo Teck Puat - National University Children's Medical Institute, National University Health System, Singapore.
Yap-Seng ChongSingapore Institute for Clinical Sciences, Agency for Science Technology and Research (A⁎STAR), Singapore; Department of Obstetrics & Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore.
Peter D GluckmanSingapore Institute for Clinical Sciences, Agency for Science Technology and Research (A⁎STAR), Singapore; Liggins Institute, University of Auckland, Auckland, New Zealand.
Keith M GodfreyMRC Lifecourse Epidemiology Unit; Southampton, United Kingdom; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
Philip C CalderNIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Mary F F ChongSingapore Institute for Clinical Sciences, Agency for Science Technology and Research (A⁎STAR), Singapore; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Clinical Nutrition Research Centre (CNRC), Singapore Institute for Clinical Sciences, Centre for Translational Medicine, Singapore.
Michael S KramerDepartment of Pediatrics and of Epidemiology and Biostatistics, McGill University Faculty of Medicine, Montreal, Quebec, Canada.
Jérémie BottonU1153 Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre (CRESS), Early Origin of the Child's Health and Development (ORCHAD) Team, Inserm, Villejuif, France; Univ Paris Descartes, Villejuif, France; Faculty of Pharmacy, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Yung Seng LeeSingapore Institute for Clinical Sciences, Agency for Science Technology and Research (A⁎STAR), Singapore; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Paediatric Endocrinology and Diabetes, Khoo Teck Puat, National University Children's Medical Institute, National University Health System, Singapore.
Agency for Science, Technology and Research · SGKK Women's and Children's Hospital · SGNational University of Singapore · SGUniversity Hospital Southampton NHS Foundation Trust · GBInserm · FRMcGill University · CA

Funding

British Heart Foundation RG/15/17/31749Medical Research Council MC_U147574226Medical Research Council MC_UP_A620_1017Medical Research Council MC_UU_12011/4Medical Research Council MR/J000094/1
6 · The paper itself

Abstract

backgroundPolyunsaturated fatty acids (PUFA) are essential for offspring development, but it is less clear whether pregnancy PUFA status affects growth and adiposity.

methodsIn 985 mother-offspring pairs from the ongoing Singaporean GUSTO cohort, we analyzed the associations between offspring growth and adiposity outcomes until age 5 years and five PUFAs of interest, measured in maternal plasma at 26-28 weeks' gestation: linoleic acid (LA), arachidonic acid, α-linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid (DHA). We measured fetal growth by ultrasound (n=924), neonatal body composition (air displacement plethysmography (n=252 at birth, and n=317 at age 10 days), and abdominal magnetic resonance imaging (n=317)), postnatal growth (n=979) and skinfold thicknesses (n=981). Results were presented as regression coefficients for a 5% increase in PUFA levels.

resultsLA levels were positively associated with birthweight (β (95% CI): 0.04 (0.01, 0.08) kg), body mass index (0.13 (0.02, 0.25) kg/m

conclusionsLA was positively associated with neonatal body size, and DHA with child height. Maternal PUFA status during pregnancy may influence fetal and child growth and adiposity.

Indexed as

Adiposityalpha-Linolenic AcidBirth WeightBody CompositionBody Mass IndexChild DevelopmentChild, PreschoolDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, UnsaturatedFemaleGestational AgeHumansInfantInfant, NewbornMalealpha-Linolenic AcidDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, UnsaturatedPhosphatidylcholinesAdiposityBody compositionFetal growthGrowth modellingInfant growthPolyunsaturated fatty acids

Identifiers

PMID28651694
PMCPMC5501311
OpenAlexW2621775723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.